J&J subsidiary proposes paying about $6.48B over 25 years to settle talc ovarian cancer lawsuits
Yahoo Finance - 2024-05-01T11:15:17.000Z

A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer. The lawsuits filed against J&J had alleged its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs. The claims contributed to drop in J&J’s sales of baby powder, prompting the...

In related news

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
- Related Articles
- In News
- From CNBC
- 2024-05-01T10:31:53.000Z
Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits
Deal would resolve tens of thousands of lawsuits alleging company's baby powder causes ovarian cancer.
- Related Articles
- In News
- From The Guardian
- 2024-05-01T12:25:13.000Z
Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims
The plan is expected to resolve 99.75% of all pending talc lawsuits against the company and its units in the U.S., it said in a statement.
- Related Articles
- In News
- From MarketWatch
- 2024-05-01T10:52:00.000Z

In related news

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits

Johnson & Johnson unveils latest plan to settle ovarian cancer talc claims